Format

Send to

Choose Destination
Prostate Cancer Prostatic Dis. 2009;12(3):269-76. doi: 10.1038/pcan.2009.8. Epub 2009 Mar 17.

Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes.

Author information

1
Faculty Division the Norwegian Radium Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway. arne.berg@radiumhospitalet.no

Abstract

We assessed self-reported health-related quality of life (HRQoL) and longitudinal changes in sex hormones among 86 prostate cancer (PCa) patients without distant metastases 5 years after radiotherapy (RT) combined with ongoing antiandrogen (AA) treatment. HRQoL outcomes were compared with scores from age-matched controls without a cancer diagnosis (NORM). Compared with NORM, patients scored statistically (P<0.05) and clinically (effect size >or=0.4) lower on sexual domains, and statistically (P<0.05) lower on physical function and vitality. Estimated free testosterone and measured serum estradiol had increased from baseline in most patients, but did not correlate with HRQoL outcomes 5 years after the start of treatment.

PMID:
19290019
DOI:
10.1038/pcan.2009.8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for Norwegian BIBSYS system
Loading ...
Support Center